Full Year 2022 Cosmo Pharmaceuticals NV Earnings Call Transcript
Ladies and gentlemen, welcome to the -- Cosmo's Full Year 2022 Results and 2023 Outlook Conference Call and Webcast. I'm Ira, the Conference Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Mr. Mauro Ajani, Founder and Chairman. Please go ahead, sir.
First of all, thank you, and good morning, everyone. Let me say that I am very happy and extremely excited today to be here. It was important for me to share with all of you my perspective on the great things that are happening here at Cosmo, and we have many great things that's happening. But today, I would like to focus on GI Genius.
I am sure that you read the different press release from us from Medtronic and also from NVIDIA. And I am sure you already realized how big and how important and strategic this news is. Let me say that we are at a pivotal moment with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |